New TNM classification for non-small-cell lung cancer.
The International Association for the Study of Lung Cancer (IASLC) staging committee has recently completed a decade of work devoted to updating the stage classification system for lung cancer. The IASLC has proposed revisions based on the evaluation of outcomes in an extensive worldwide database. This review outlines the changes in the tumor, node, metastasis (TNM) descriptors and stage groupings anticipated in the official new stage classification system for non-small-cell lung cancer with the forthcoming publication of the 7th Edition of the stage classification.
Section of Pulmonary and Critical Care Medicine, Yale Thoracic Oncology Program, Yale School of Medicine, 105 LCI, 333 Cedar Street, New Haven, CT 06520, USA. lynn.tanoue@yale.edu
Lynn T
LT
Tanoue
Frank C
FC
Detterbeck
D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000556:secondary; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D047368:Tumor Burden